[Pseudomonas aeruginosa: Pathogenicity and antimicrobial resistance in urinary tract infection]. 2019

Victor Manuel Paz-Zarza, and Simran Mangwani-Mordani, and Alejandra Martínez-Maldonado, and Diego Álvarez-Hernández, and Sandra Georgina Solano-Gálvez, and Rosalino Vázquez-López
Centro de Investigación en Ciencias de la Salud, Facultad de Ciencias de la Salud, Universidad Anáhuac México Campus Norte, Estado de México, México.

Among the most frequent nosocomial infections associated with polyresistant bacteria and with a worse prognosis, are those produced by Pseudomonas aeruginosa. This bacterium has a high capacity to adapt to adverse conditions such as pH and osmolarity of urine. Pseudomonas aeruginosa is one of the main pathogens involved in nosocomial infections and immunosuppressed patients. This bacterium is considered an opportunistic infectious agent that has diverse mechanisms of pathogenicity, as well as resistance to antimicrobials, which contributes to the difficulty in the treatment of these infections. In the present bibliographic review, the taxonomy, pathogenicity mechanisms and resistance genes of P. aeruginosa are analyzed. Likewise, the micro-environmental factors of the urinary infection produced by this bacterium are approached, making an approach to the understanding of the pathophysiological bases of this infection.

UI MeSH Term Description Entries
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection
D018441 Biofilms Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents. Biofilm
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance
D037521 Virulence Factors Those components of an organism that determine its capacity to cause disease but are not required for its viability per se. Two classes have been characterized: TOXINS, BIOLOGICAL and surface adhesion molecules that effect the ability of the microorganism to invade and colonize a host. (From Davis et al., Microbiology, 4th ed. p486) Pathogenicity Factor,Pathogenicity Factors,Virulence Factor,Factor, Pathogenicity,Factor, Virulence,Factors, Pathogenicity,Factors, Virulence

Related Publications

Victor Manuel Paz-Zarza, and Simran Mangwani-Mordani, and Alejandra Martínez-Maldonado, and Diego Álvarez-Hernández, and Sandra Georgina Solano-Gálvez, and Rosalino Vázquez-López
June 2018, Journal of medical microbiology,
Victor Manuel Paz-Zarza, and Simran Mangwani-Mordani, and Alejandra Martínez-Maldonado, and Diego Álvarez-Hernández, and Sandra Georgina Solano-Gálvez, and Rosalino Vázquez-López
October 1993, Tropical doctor,
Victor Manuel Paz-Zarza, and Simran Mangwani-Mordani, and Alejandra Martínez-Maldonado, and Diego Álvarez-Hernández, and Sandra Georgina Solano-Gálvez, and Rosalino Vázquez-López
October 1991, Nihon rinsho. Japanese journal of clinical medicine,
Victor Manuel Paz-Zarza, and Simran Mangwani-Mordani, and Alejandra Martínez-Maldonado, and Diego Álvarez-Hernández, and Sandra Georgina Solano-Gálvez, and Rosalino Vázquez-López
November 1978, Infection and immunity,
Victor Manuel Paz-Zarza, and Simran Mangwani-Mordani, and Alejandra Martínez-Maldonado, and Diego Álvarez-Hernández, and Sandra Georgina Solano-Gálvez, and Rosalino Vázquez-López
February 2023, Biosensors & bioelectronics,
Victor Manuel Paz-Zarza, and Simran Mangwani-Mordani, and Alejandra Martínez-Maldonado, and Diego Álvarez-Hernández, and Sandra Georgina Solano-Gálvez, and Rosalino Vázquez-López
December 2002, International journal of antimicrobial agents,
Victor Manuel Paz-Zarza, and Simran Mangwani-Mordani, and Alejandra Martínez-Maldonado, and Diego Álvarez-Hernández, and Sandra Georgina Solano-Gálvez, and Rosalino Vázquez-López
April 2016, Pediatrics,
Victor Manuel Paz-Zarza, and Simran Mangwani-Mordani, and Alejandra Martínez-Maldonado, and Diego Álvarez-Hernández, and Sandra Georgina Solano-Gálvez, and Rosalino Vázquez-López
November 2011, Journal of medical microbiology,
Victor Manuel Paz-Zarza, and Simran Mangwani-Mordani, and Alejandra Martínez-Maldonado, and Diego Álvarez-Hernández, and Sandra Georgina Solano-Gálvez, and Rosalino Vázquez-López
December 1997, Pediatric nephrology (Berlin, Germany),
Victor Manuel Paz-Zarza, and Simran Mangwani-Mordani, and Alejandra Martínez-Maldonado, and Diego Álvarez-Hernández, and Sandra Georgina Solano-Gálvez, and Rosalino Vázquez-López
February 1997, Pediatric nephrology (Berlin, Germany),
Copied contents to your clipboard!